• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cannara Biotech Inc (OP:LOVFF)

1.440 UNCHANGED
Delayed Quote Updated: 10:02 AM EDT, Oct 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.440
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 1.440
Today's Range 1.440 - 1.440
52wk Range 1.109 - 1.660
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
OTC Markets Group Welcomes Cannara Biotech Inc. to OTCQX
January 14, 2026
From OTC Markets
Via GlobeNewswire
News headline image
Presenting at the Investor Summit Q3 2025 on September 16; Watch the Live Stream for Free
September 16, 2025
Via ACCESS Newswire

Performance

52-Week Range 13.3% below 52-week high
1.440
1.1152W Low 1.6652W High
1 Week 2.0% below 1-week high
1.441W Low 1.471W High

Cannara Biotech Inc (LOVFF) traded between $1.11 and $1.66 over the past 52 weeks and last traded at $1.44, 13.3% below its 52-week high. Over the past week it ranged between $1.44 and $1.47.

Past 12 Months
-1.8%
-0.4%
+10.8%
+8.3%
+10.8%
+20.0%
1W -$0.03
1M -$0.01
3M +$0.14
6M +$0.11
YTD +$0.14
1Y +$0.24

LOVFF was +20.0% over the past year, +8.3% over six months, +10.8% year to date, -1.8% in the last week.

12 Months vs Market
LOVFF
+20.0%
DIA
+12.3%
SPY
+14.6%
QQQ
+17.3%
IWM
+11.1%

Over the past 12 months LOVFF returned +20.0% versus DIA (Dow) +12.3%, SPY (S&P 500) +14.6%, QQQ (Nasdaq 100) +17.3% and IWM (Russell 2000) +11.1%.

Volume & Liquidity
1W
2.4K
1M
7.2K
3M
5.3K
6M
12.6K
YTD
10.9K
1Y
10.3K

LOVFF's 3-month average daily volume is 5.3K.

More News

Read More
News headline image
Cannara Announces Proposed Settlement of Convertible Debenture via Share Issuance
October 02, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Biotech Delivers Highest Revenue and Profitability Since Inception in Fiscal Q3 2025
July 28, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Announces Grant of Options and RSUs
September 01, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
This Week In Cannabis: Maryland Opens Lounges, DEA Wavers, Retail Trends Shift And More ↗
May 02, 2025
Via Benzinga
Topics Cannabis
News headline image
Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates
April 28, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Announces Amendment and Upsize of BMO Credit Facility to Support Facility Expansion at Valleyfield
August 21, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Biotech to Present at The Ventum Canadian Cannabis Conference on March 12th, 2025
March 06, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Biotech Enhances Financial Flexibility Through Strategic Asset Sale
August 14, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Biotech Reports Record Q1 2025 Revenue and National Market Share, Sets Stage for Continued Momentum in 2025
January 27, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Secures 5 Key Listings in Québec’s New Vape Cartridge Category Including to be Released Live Rosin Vapes
July 24, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024
December 12, 2024
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Biotech Inc. to Announce Fiscal Q3 2025 Financial Results on July 28, 2025
July 21, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand ↗
December 05, 2024
Via Benzinga
Topics Cannabis
News headline image
Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash Flow ↗
December 04, 2024
Via Benzinga
Topics Cannabis
News headline image
Cannara Biotech to Host Investor Webcast on June 25th, 2025
June 19, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Canadian Cannabis Producer Cannara Reports 43% YoY Revenue Growth, Boosts Market Share And Profitability ↗
November 25, 2024
Via Benzinga
Topics Cannabis
News headline image
Cannara Reduces Cost of Debt with Lower Interest Rate and Partial Debenture Repayment; Wins 2025 Brand of the Year
June 18, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market
November 25, 2024
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025
April 16, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Canada's Cannabis Market Goes Cold, Pot Prices Hit Bottom: Why Top Producers Are Losing Ground ↗
October 29, 2024
Via Benzinga
Topics Cannabis
News headline image
Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors
March 24, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Announces Extension of BMO Credit Facility and Convertible Debenture to Enhance Financial Flexibility and Support Execution of its Long-Term Strategy
February 24, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike
December 16, 2024
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Cannara Biotech Inc publicly traded?
Yes, Cannara Biotech Inc is publicly traded.
What exchange does Cannara Biotech Inc trade on?
Cannara Biotech Inc trades on the OTC Traded
What is the ticker symbol for Cannara Biotech Inc?
The ticker symbol for Cannara Biotech Inc is LOVFF on the OTC Traded
What is the current price of Cannara Biotech Inc?
The current price of Cannara Biotech Inc is 1.440
When was Cannara Biotech Inc last traded?
The last trade of Cannara Biotech Inc was at 10/20/26 10:02 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap